glp-1 vs bariatric surgery or GLP-1's: Which weight loss treatment is right for you? Choosing Between Weight Loss Medications

Recently, in addition to the central maintenance of food intake, GLP-1R signaling has begun to be considered in the context of the regulation of the stress response, as it is indicated that it can activate both the hypothalamicpituitaryadrenal (HPA) axis as well as the sympathetic nervous system [15, 16]

In 1992, scientists discovered exendin-4 and began developing synthetic versions for human use

Abstract Importance Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with increased risk of diabetic retinopathy (DR) and nonarteritic anterior ischemic optic neuropathy (NAION)

Compounded GLP-1 Preparations (Not FDA-Approved) Considered only when an FDA-approved alternative is unavailable or clinically inappropriate for an individual patient (503A) or supplied for office use where permitted by law

The on-label and off-label use of GLP1RAs has gained popularity, driven by robust clinical research, documented benefits, and widely circulated claims on social media [1]

ChristianaCare study finds most patients can continue GLP-1 drugs before gynecologic surgery WILMINGTON Most patients taking widely used weight-loss and diabetes medications can safely continue those drugs before gynecologic surgery, according to a new journal article from ChristianaCare published in Obstetrics & Gynecology